Related references
Note: Only part of the references are listed.Recent Advancements on Benzimidazole: A Versatile Scaffold in Medicinal Chemistry
Zohor Mohammad Mahdi Alzhrani et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2022)
Synthesis and evaluation of 2-(4-[4-acetylpiperazine-1-carbonyl] phenyl)-1H-benzo[d]imidazole-4-carboxamide derivatives as potential PARP-1 inhibitors and preliminary study on structure-activity relationship
Miaojia Chen et al.
DRUG DEVELOPMENT RESEARCH (2022)
Modulation of cGAS-STING Pathway by Nicotinamide Riboside in Alzheimer's Disease
James W. Larrick et al.
REJUVENATION RESEARCH (2021)
Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes
Mohammed T-E Maghraby et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Design, Synthesis, and Biological Evaluation of Amidobenzimidazole Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists
Qiumu Xi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Synthesis of Some Benzimidazole-derived Molecules and their Effects on PARP-1 Activity and MDA-MB-231, MDA-MB-436, MDA-MB-468 Breast Cancer Cell Viability
A. Selen Gurkan-Alp et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2020)
An Alternative Splicing of Tupaia STING Modulated Anti-RNA Virus Responses by Targeting MDA5-LGP2 and IRF3
Ling Xu et al.
JOURNAL OF IMMUNOLOGY (2020)
Structural basis for allosteric PARP-1 retention on DNA breaks
Levani Zandarashvili et al.
SCIENCE (2020)
Research Advances in How the cGAS-STING Pathway Controls the Cellular Inflammatory Response
Dongshan Wan et al.
FRONTIERS IN IMMUNOLOGY (2020)
Design, synthesis and biological evaluation of novel fluoro-substituted benzimidazole derivatives with anti-hypertension activities
Zhuo Wu et al.
BIOORGANIC CHEMISTRY (2020)
Synthetic lethality strategies: Beyond BRCA1/2 mutations in pancreatic cancer
Yunlong Hu et al.
CANCER SCIENCE (2020)
Structures and Mechanisms in the cGAS-STING Innate Immunity Pathway
Xuewu Zhang et al.
IMMUNITY (2020)
Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific Manner
Jinu Abraham et al.
FRONTIERS IN IMMUNOLOGY (2020)
Design, Synthesis and Anti-Tumor Activity of Novel Benzimidazole-Chalcone Hybrids as Non-Intercalative Topoisomerase II Catalytic Inhibitors
Wei Zhou et al.
MOLECULES (2020)
The cGAS-STING pathway: The role of self-DNA sensing in inflammatory lung disease
Ruihua Ma et al.
FASEB JOURNAL (2020)
Radiation therapy enhanced therapeutic efficacy of anti-PD1 against gastric cancer
Sen Hong et al.
JOURNAL OF RADIATION RESEARCH (2020)
Saururus chinensis-controlled allergic pulmonary disease through NF-κB/COX-2 and PGE2 pathways
MiKyung Song et al.
PEERJ (2020)
Potential for Protein Kinase Pharmacological Regulation in Flaviviridae Infections
Ana-Belen Blazquez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer
Quinn Storozynsky et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Novel benzimidazole derivatives as anti-cervical cancer agents of potential multi-targeting kinase inhibitory activity
Eman A. Abd El-Meguid et al.
ARABIAN JOURNAL OF CHEMISTRY (2020)
Abemaciclib: The Newest CDK4/6 Inhibitor for the Treatment of Breast Cancer
Alison Palumbo et al.
ANNALS OF PHARMACOTHERAPY (2019)
Synthesis, biological evaluation and molecular docking of benzimidazole grafted benzsulfamide-containing pyrazole ring derivatives as novel tubulin polymerization inhibitors
Yan-Ting Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
New benzimidazothiazole derivatives as anti-inflammatory, antitumor active agents: Synthesis, in-vitro and in-vivo screening and molecular modeling studies
Mohamed M. El-Kerdawy et al.
BIOORGANIC CHEMISTRY (2019)
Design and synthesis of novel PARP-1 inhibitors based on pyridopyridazinone scaffold
Ghada F. Elmasry et al.
BIOORGANIC CHEMISTRY (2019)
Recent development of CDK inhibitors: An overview of CDK/inhibitor co-crystal structures
Weiyan Cheng et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery of 2-(1-(3-(4-Chloroxyphenyl)-3-oxo- propyl)pyrrolidine-3-yl)-1H-benzo[d]imidazole-4-carboxamide: A Potent Poly(ADP-ribose) Polymerase (PARP) Inhibitor for Treatment of Cancer
Rui Min et al.
MOLECULES (2019)
A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signalling
Jin-Cherng Lien et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Mutagenic Study of Benzimidazole Derivatives with (+S9) and without (-S9) Metabolic Activation
Nurul Hafizan Azahar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Design, synthesis and evaluation of phthalazinone thiohydantoin-based derivative as potent PARP-1 inhibitors
Yi Zhong et al.
BIOORGANIC CHEMISTRY (2019)
Design, synthesis and in vitro evaluation of 6-amide-2-aryl benzoxazole/benzimidazole derivatives against tumor cells by inhibiting VEGFR-2 kinase
Xu Yuan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Cell Cycle-Dependent Control and Roles of DNA Topoisomerase II
Joyce H. Lee et al.
GENES (2019)
Design, synthesis, and biological evaluation of new pyrazino[1,2-a]benzimidazole derivatives as selective cyclooxygenase (COX-2) inhibitors
Mahsa Azami Movahed et al.
ARCHIV DER PHARMAZIE (2019)
Design and synthesis of 2-phenyl benzimidazole derivatives as VEGFR-2 inhibitors with anti-breast cancer activity
Amany S. Mostafa et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2019)
Abemaciclib Inhibits Renal Tubular Secretion Without Changing Glomerular Filtration Rate
Jill C. Chappell et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Water-Assisted Self-Aggregation of Benzimidazole and Triazole Adducts
Ishani I. Sahay et al.
ACS OMEGA (2019)
Metagenomic insights into the ecology and physiology of microbes in bioelectrochemical systems
Atsushi Kouzuma et al.
BIORESOURCE TECHNOLOGY (2018)
Design and synthesis of 2-(4,5,6,7-tetrahydrothienopyridin-2-yl)-benzoimidazole carboxamides as novel orally efficacious Poly(ADP-ribose)polymerase (PARP) inhibitors
Xuxing Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Abemaciclib for the treatment of breast cancer
Takeshi Kotake et al.
EXPERT OPINION ON PHARMACOTHERAPY (2018)
Structure and Chromosomal Organization of Yeast Genes Regulated by Topoisomerase II
Ricky S. Joshi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Isorhamnetin suppresses PANC-1 pancreatic cancer cell proliferation through S phase arrest
Jia-Li Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Molecular Characterization, Expression and Functional Analysis of Chicken STING
Jin-Shan Ran et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Discovery of 2-substituted 1H-benzo[d]immidazole-4-carboxamide derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors with in vivo anti-tumor activity
Jie Zhou et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Novel pyrazolo[3,4-d]pyrimidine with 4-(1H-benzimidazol-2-y1)-phenylamine as broad spectrum anticancer agents: Synthesis, cell based assay, topoisomerase inhibition, DNA intercalation and bovine serum albumin studies
Prinka Singla et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Selective Inhibition of Escherichia coli RNA and DNA Topoisomerase I by Hoechst 33258 Derived Mono- and Bisbenzimidazoles
Nihar Ranjan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis, molecular docking and biological evaluation of 1-phenylsulphonyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as novel potential tubulin assembling inhibitors
Yan-Ting Wang et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2017)
In vivo anti-inflammatory activity and docking study of newly synthesized benzimidazole derivatives bearing oxadiazole and morpholine rings
Ankita Rathore et al.
BIOORGANIC CHEMISTRY (2017)
Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity
Edyta Lukowska-Chojnacka et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Design, synthesis and biological evaluation of novel 5-fluoro-1H-benzimidazole-4-carboxamide derivatives as potent PARP-1 inhibitors
Junwei Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Nocodazole Induced Suicidal Death of Human Erythrocytes
Elena Signoretto et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer
H. S. Rugo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model
Tara Williamson et al.
ONCOTARGET (2016)
Therapeutic Potential of Denosumab in Patients With Lung Cancer: Beyond Prevention of Skeletal Complications
Javier De Castro et al.
CLINICAL LUNG CANCER (2015)
COX inhibitors: a patent review (2011-2014)
Sara Consalvi et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2015)
A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation - An NRG Oncology/Gynecologic Oncology Group study
Robert L. Coleman et al.
GYNECOLOGIC ONCOLOGY (2015)
EGCG regulates the cross-talk between JWA and topoisomerase IIα in non-small-cell lung cancer (NSCLC) cells
Yuan Li et al.
SCIENTIFIC REPORTS (2015)
Assessment of molecular binding of Hoechst 33258 analogues into DNA using docking and MM/GBSA approach
Upasana Issar et al.
JOURNAL OF COMPUTATIONAL SCIENCE (2015)
Inhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer Therapy
Yang Xu et al.
BIOMOLECULES (2015)
1-Methyl-2-methylsulfanyl-6-nitro-1H-benzimidazole
Mohamed El Ghozlani et al.
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE (2014)
Drug repositioning from bench to bedside: Tumour remission by the antihelmintic drug mebendazole in refractory metastatic colon cancer
Peter Nygren et al.
ACTA ONCOLOGICA (2014)
Design of novel bis-benzimidazole derivatives as DNA minor groove binding agents
Xiu-Jun Wang et al.
CHINESE CHEMICAL LETTERS (2014)
Benzimidazole: An emerging scaffold for analgesic and anti-inflammatory agents
Monika Gaba et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Tubulin inhibitors: a patent review
Yi-Min Liu et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2014)
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Seng-Ryong Woo et al.
IMMUNITY (2014)
A COX-2 inhibitor enhances the antitumor effects of chemotherapy and radiotherapy for esophageal squamous cell carcinoma
Gulbostan Yusup et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
STING-Mediated DNA Sensing Promotes Antitumor and Autoimmune Responses to Dying Cells
Jared Klarquist et al.
JOURNAL OF IMMUNOLOGY (2014)
The cGAS-cGAMP-STING Pathway of Cytosolic DNA Sensing and Signaling
Xin Cai et al.
MOLECULAR CELL (2014)
Novel DNA Topoisomerase IIα Inhibitors from Combined Ligand- and Structure-Based Virtual Screening
Malgorzata N. Drwal et al.
PLOS ONE (2014)
The role of angiogenic factors in endometrial cancer
Monika Magdalena Zyla et al.
MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY (2014)
Selective inhibition of bacterial topoisomerase I by alkynyl-bisbenzimidazoles
Nihar Ranjan et al.
MEDCHEMCOMM (2014)
Mitogen-Activated Protein (MAP) Kinase Scaffolding Proteins: A Recount
Melanie Meister et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA
Jiaxi Wu et al.
SCIENCE (2013)
Cloning and functional characterization of rat stimulator of interferon genes (STING) regulated by miR-24
Zhiqing Huang et al.
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY (2012)
Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors
Yunqi Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Novel angiogenesis inhibitors: Addressing the issue of redundancy in the angiogenic signaling pathway
Domenico Ribatti
CANCER TREATMENT REVIEWS (2011)
Cyclooxygenase-2 in oncogenesis
Maria Teresa Rizzo
CLINICA CHIMICA ACTA (2011)
Synthesis and biological activity of novel inhibitors of topoisomerase I: 2-Aryl-substituted 2-bis-1H-benzimidazoles
Manish Singh et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Albendazole inhibits endothelial cell migration, tube formation, vasopermeability, VEGF receptor-2 expression and suppresses retinal neovascularization in ROP model of angiogenesis
Mohammad H. Pourgholami et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Minor groove dimeric bisbenzimidazoles inhibit in vitro DNA binding to eukaryotic DNA topoisomerase I
O. Yu. Susova et al.
BIOCHEMISTRY-MOSCOW (2010)
Casein Kinase II: An attractive target for anti-cancer drug design
Ismail Muhamad Hanif et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Design, Structure-Activity Relationships and in Vivo Characterization of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A Novel Class of Receptor Tyrosine Kinase Inhibitors
Paul A. Renhowe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Halogen substitution of DNA protects from poisoning of topoisomerase II that results in DNA double-strand breaks
Gloria Cantero et al.
DNA REPAIR (2006)
Topoisomerase Enzymes as Therapeutic Targets for Cancer Chemotherapy
Gregory I. Giles et al.
MEDICINAL CHEMISTRY (2005)
Progression through the G1-phase of the on-going cell cycle
J Boonstra
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Is MK2 (mitogen-activated protein kinase-activated protein kinase 2) the key for understanding post-transcriptional regulation of gene expression?
A Kotlyarov et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2002)
DNA topoisomerase I from mycobacteria - A potential drug target
V Nagaraja et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
DNA topoisomerase VI generates ATP-dependent double-strand breaks with two-nucleotide overhangs
C Buhler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cyclooxygenase-2: a novel target for cancer chemotherapy?
W Dempke et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2001)
Fission yeast homolog of murine int-6 protein, encoded by mouse mammary tumor virus integration site, is associated with the conserved core subunits of eukaryotic translation initiation factor 3
Y Akiyoshi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
